Key statistics
As of last trade Bicycle Therapeutics PLC (BCYC:NSQ) traded at 5.68, 7.69% above its 52-week low of 5.27, set on Feb 05, 2026.
52-week range
| Open | 5.83 |
|---|---|
| High | 5.95 |
| Low | 5.61 |
| Bid | 5.65 |
| Offer | 5.70 |
| Previous close | 5.78 |
| Average volume | 573.19k |
|---|---|
| Shares outstanding | 69.37m |
| Free float | 4.33m |
| P/E (TTM) | -- |
| Market cap | 392.62m USD |
| EPS (TTM) | -3.62 USD |
Data delayed at least 15 minutes, as of Feb 10 2026 19:17 GMT.
More ▼
- Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline
- Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026
- Bicycle Therapeutics Establishes Multiple Strategic Partnerships to Create End-to-End Supply Chain to Support its Wholly Owned Radiopharmaceutical Pipeline
- Ankyra Appoints Sailaja Battula, PhD as Chief Scientific Officer (CSO)
- Cassidy Bio Launches with the Goal to Develop Safer, More Scalable Gene Editing Therapies
- Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference
More ▼
